Women in Biotech - Oxford
Growing successfully in challenging times
BIA's Women in Biotech series is returning to Oxford this Autumn! Join us this September when we are thrilled to be hosted by Evotec at Milton Park. The expert panel of leaders in the biotech industry will share their challenges and successes over the last two years. They will discuss practical experiences of being leaders in the changing environments and what they see as the success factors to thriving and growing in shifting environments.
In addition to the inspirational speakers, you can expect some excellent networking over refreshments. Book now to secure your place. We’re looking forward to it already!
Dianne is Managing Director of DLRC Ltd, UK and Orphix Consulting GmbH, Germany - two of the three companies that form the DLRC Group. DLRC Group is a leading Regulatory Affairs consultancy employing more than 80 consultants who provide comprehensive strategic and operational support to the pharmaceutical, biotechnology, medical technology, and related industries across major markets.
Dianne founded DLRC in 2005 and has nearly 40 years’ experience in the Pharma Industry.
DLRC is the winner of multiple awards including two Queens Awards for Enterprise: International Trade awards in 2017 and 2021 and a Hertfordshire Employer of the Year and Business Growth award winner. Dianne was awarded the TOPRA Inspiration award and last year was winner of the Hertfordshire and Eastern Region Chambers of Commerce award for Entrepreneur of the Year, making her a finalist in the National Chamber awards.
Priya Mande is a founding member of PsiOxus with 30 years of experience in the pharmaceutical and biotech sector. She joined the PsiOxus Board of Directors in 2016. Since 2010, she has overseen the growth of PsiOxus in the UK and USA holding responsibility for corporate development, project management, clinical, QA, finance, legal and operations as Chief Operating Officer.
In 2020, she was seconded to the prestigious UK Vaccine Taskforce in the fight against Covid-19. Priya has previously worked at GlaxoSmithKline where she was R&D Strategy Director supporting the R&D Executive. She also held roles across research, development, finance and business strategy whilst at GSK. At PowderMed, she was responsible for delivery of the vaccine portfolio which sold to Pfizer for over US$300 million in 2006. Priya subsequently became the Vaccine Research Project Leader for Influenza at Pfizer. Priya studied Applied Biochemistry at Brunel University London, received her MBA with distinction from the London Business School and was awarded Chartered Director status by the UK Institute of Directors in 2020.
Kathryn is a respected and successful change leadership expert, with diverse career experience in Europe and North America. She has over 25 years of consulting and line experience with leading organisations (Unilever, Mars, KPMG and GSK). Since 2007 she has been leading her own independent consulting business, primarily working within the Life Sciences sector. By partnering with leaders at all levels within the sector, growth and sustainable success has resulted for the organisations she has worked with. She has recently published a book – “Leading for change – how to thrive during uncertain times”.
She provides each organisation the approaches they need to meet their unique situation. Tailored approaches are used to develop a consolidated understanding of their environment and the priority challenges they face. This provides the basis for facilitating customised workshops where leaders not only create a desired future but are ready to move forward and implement their ideas. Working with individual leaders or teams she advises how to bring other stakeholders with them, so they achieve success together. These practical and supportive approaches create focus, accountability and collaboration across organisations and their partners. Organisations are left with an increased leadership capability and tangible business results.
Annelise joined Immunocore (Avidex) when it was founded in 2000 and has played a lead role in the design and engineering of the ImmTAX platform, a novel class of TCR based bispecifics. She is currently leading Immunocore’s drug discovery pipeline and research to expand the ImmTAX technology further. Before joining Immunocore, Annelise was a postdoctoral researcher in the Biochemistry department in University College London. She gained her PhD in 1998 in Biophysics from the University of Paris.
Members £30.00 +vat
Non-members £40.00 +vat
By registering to this event you accept our Terms & Conditions
VENUE AND EVENT ACCESSIBILITY
We are regularly monitoring changes on government regulations around events. We recommend all attendees take a lateral flow test no more than 24 hours prior to the event. We advise any attendees who are not feeling well or who are displaying Covid-19 symptoms to please not attend.
Alternative or additional precautions like the wearing of masks inside the venue might also be considered and requested.
If you have any questions or problems registering, please contact Sam Care - [email protected]
16:30 – 17:30 Registration and networking
17:30 – 18:30 Panel session and Q&A
- Diane Lee, Managing Director, DLRC
- Priya Mande, Interim CEO, PsiOxus
- Kathryn Simpson, Kathryn Simpson Consulting
- Annelise Vuidepot, Chief Technology Officer & Head of Pipeline and Platform Research
18:30 – 20:00 Networking/drinks reception
Thank you to our event hosts:
Thank you to our Women in biotech series supporter: